喵ID:8aR1yq免责声明

Effect of a memory-enhancing drug, AIT-082, on the level of synaptophysin

基本信息

DOI:
10.1111/j.1749-6632.2000.tb06390.x
发表时间:
2000-01-01
期刊:
VASCULAR FACTORS IN ALZHEIMER'S DISEASE
影响因子:
--
通讯作者:
Farlow, MR
中科院分区:
其他
文献类型:
Article;Proceedings Paper
作者: Lahiri, DK;Ge, YW;Farlow, MR研究方向: -- MeSH主题词: --
关键词: --
来源链接:pubmed详情页地址

文献摘要

Our objective is to study the effect of AIT-082 on the level of synaptophysin in cultured pheochromocytoma (PC12) cells. The drug AIT-082, a unique purine hypoxanthine derivative, is under development for the treatment of Alzheimer's disease (AD), We analyzed synaptophysin protein as an index of synaptic numbers and density and indirectly nenronal transmission. PC12 cells were treated with nerve growth factor (NGF) (50 ng/ml) and/or different doses of AIT-082 (5-50 ng/ml) obtained from NeoTherapeutics, CA. In the western immunoblots of conditioned media and cell lysates, we detected synaptophysin as 36-40 kDa protein bands. When PC12 cells were treated with NGF and samples were analyzed at 24 or 48 hours after treatment, the secretion of synaptophysin was drastically reduced in the conditioned medium. A significant reduction in the intracellular level of synaptophysin in NGF-treated samples was also noted, By contrast, when PC12 cells were treated with AIT-082, the secretion of synaptophysin was increased in the conditioned medium as compared to the control, There was also a significant increase in the intracellular levels of synaptophysin in AIT-082-treated cultures. NGF treatment resulted in sympathetic neuronal phenotypes in PC12 cells, As it is known that the immunoreactivity of the synaptophysin protein correlates with the density of the synaptic terminal, our results suggest that treatment by AIT-082 could enhance neurotransmitter release at the presynaptic terminal, which may play a role in the improvement of cognition seen in AD subjects.
我们的目的是研究AIT - 082对培养的嗜铬细胞瘤(PC12)细胞中突触素水平的影响。药物AIT - 082是一种独特的嘌呤次黄嘌呤衍生物,正处于开发用于治疗阿尔茨海默病(AD)的过程中。我们将突触素蛋白作为突触数量和密度以及间接神经元传递的指标进行分析。PC12细胞用神经生长因子(NGF)(50纳克/毫升)和/或从加利福尼亚州新疗法公司获得的不同剂量的AIT - 082(5 - 50纳克/毫升)进行处理。在条件培养基和细胞裂解物的蛋白质免疫印迹中,我们检测到突触素为36 - 40千道尔顿的蛋白条带。当PC12细胞用NGF处理且在处理后24或48小时对样本进行分析时,条件培养基中突触素的分泌急剧减少。在NGF处理的样本中,突触素的细胞内水平也显著降低。相比之下,当PC12细胞用AIT - 082处理时,与对照组相比,条件培养基中突触素的分泌增加。在AIT - 082处理的培养物中,突触素的细胞内水平也显著增加。NGF处理使PC12细胞呈现交感神经元表型。由于已知突触素蛋白的免疫反应性与突触末端的密度相关,我们的结果表明AIT - 082处理可增强突触前末端的神经递质释放,这可能在阿尔茨海默病患者认知改善中起作用。
参考文献(11)
被引文献(0)

数据更新时间:{{ references.updateTime }}

Farlow, MR
通讯地址:
--
所属机构:
--
电子邮件地址:
--
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓